Cargando…
Structure and inhibition mechanism of the human citrate transporter NaCT
Citrate is most well-known as an intermediate in the TCA cycle of the cell. In addition to this essential role in energy metabolism, the tricarboxylate anion also acts as both a precursor and a regulator of fatty acid synthesis (1–3). Thus, the rate of fatty acid synthesis correlates directly with t...
Autores principales: | Sauer, David B., Song, Jinmei, Wang, Bing, Hilton, Jacob K., Karpowich, Nathan K., Mindell, Joseph A., Rice, William J., Wang, Da-Neng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933130/ https://www.ncbi.nlm.nih.gov/pubmed/33597751 http://dx.doi.org/10.1038/s41586-021-03230-x |
Ejemplares similares
-
Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5)
por: Huard, Kim, et al.
Publicado: (2015) -
The Hepatic Plasma Membrane Citrate Transporter NaCT (SLC13A5) as a Molecular Target for Metformin
por: Kopel, Jonathan, et al.
Publicado: (2020) -
Model‐Based Assessment of Plasma Citrate Flux Into the Liver: Implications for NaCT as a Therapeutic Target
por: Li, Z, et al.
Publicado: (2016) -
L-Arginine and Cardioactive Arginine Derivatives as Substrates and Inhibitors of Human and Mouse NaCT/Nact
por: Surrer, Daniela B., et al.
Publicado: (2022) -
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
por: Kumar, Avi, et al.
Publicado: (2021)